BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19545054)

  • 1. [Design, synthesis and antalgic activities of aralkyl-ketone-4-piperidol derivatives].
    Wang G; Zhang GS; Guo L; Chen J; Li JQ
    Yao Xue Xue Bao; 2009 Apr; 44(4):371-8. PubMed ID: 19545054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synthesis and analgesic activities of phenyl piperazinyl aralkyl ketone derivatives].
    Xie P; Wang G; Zhang GS; Zhang L; Xu XQ; Guo L; Li JQ
    Yao Xue Xue Bao; 2012 Nov; 47(11):1511-6. PubMed ID: 23387085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Design and synthesis of aralkyl-ketone piperazine derivatives and their antalgic activities].
    Li JQ; Huang LY; Chen JX; Weng ZJ; Zhang CN
    Yao Xue Xue Bao; 2007 Nov; 42(11):1166-75. PubMed ID: 18300474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of 2,6-piperidinedione derivatives as potentially novel compounds with analgesic and other CNS activities.
    El Batran SA; Osman AE; Ismail MM; El Sayed AM
    Inflammopharmacology; 2006 Mar; 14(1-2):62-71. PubMed ID: 16835715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
    Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of novel 2,4 (1H, 3H)-quinazolinedione derivatives with analgesic and anti-inflammatory activities.
    Baraka MM
    Boll Chim Farm; 2001; 140(2):90-6. PubMed ID: 11417393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some new 1,2-benzothiazine derivatives with analgesic and anti-inflammatory activities.
    Kwon SK; Park MS
    Arzneimittelforschung; 1996 Oct; 46(10):966-71. PubMed ID: 8931890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and pharmacological evaluation of N-(dimethylamino)ethyl derivatives of benzo- and pyridopyridazinones.
    Pakulska W; Malinowski Z; Szczesniak AK; Czarnecka E; Epsztajn J
    Arch Pharm (Weinheim); 2009 Jan; 342(1):41-7. PubMed ID: 19051195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of mu and delta opioid receptors induces hyperalgesia while stimulation of kappa receptors induces antinociception in the hot plate test in the naked mole-rat (Heterocephalus glaber).
    Towett PK; Kanui TI; Juma FD
    Brain Res Bull; 2006 Dec; 71(1-3):60-8. PubMed ID: 17113929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
    Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
    J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
    Broadbear JH; Sumpter TL; Burke TF; Husbands SM; Lewis JW; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2000 Sep; 294(3):933-40. PubMed ID: 10945843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of 14-alkoxymorphinans. 21. Novel 4-alkoxy and 14-phenylpropoxy derivatives of the mu opioid receptor antagonist cyprodime.
    Spetea M; Schüllner F; Moisa RC; Berzetei-Gurske IP; Schraml B; Dörfler C; Aceto MD; Harris LS; Coop A; Schmidhammer H
    J Med Chem; 2004 Jun; 47(12):3242-7. PubMed ID: 15163203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.
    Raynor K; Kong H; Chen Y; Yasuda K; Yu L; Bell GI; Reisine T
    Mol Pharmacol; 1994 Feb; 45(2):330-4. PubMed ID: 8114680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of peripherally acting analgesic 3-arylpiperazinyl-5-benzyl-pyridazines.
    Moreau S; Coudert P; Rubat C; Albuisson E; Couquelet J
    Arzneimittelforschung; 1996 Aug; 46(8):800-5. PubMed ID: 9125282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 2. Conformational constraint in the "address" sequence.
    Arttamangkul S; Ishmael JE; Murray TF; Grandy DK; DeLander GE; Kieffer BL; Aldrich JV
    J Med Chem; 1997 Apr; 40(8):1211-8. PubMed ID: 9111295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, biological evaluation, and receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as kappa-opioid receptor agonists endowed with antinociceptive and antiamnesic activity.
    Anzini M; Canullo L; Braile C; Cappelli A; Gallelli A; Vomero S; Menziani MC; De Benedetti PG; Rizzo M; Collina S; Azzolina O; Sbacchi M; Ghelardini C; Galeotti N
    J Med Chem; 2003 Aug; 46(18):3853-64. PubMed ID: 12930147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antinociceptive activity of (5-chloro-2(3H)-benzothiazolon-3-yl)propanamide derivatives.
    Onkol T; Yildirim E; Erol K; Ito S; Sahin MF
    Arch Pharm (Weinheim); 2004 Sep; 337(9):475-81. PubMed ID: 15362119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligands.
    Calderon SN; Rice KC; Rothman RB; Porreca F; Flippen-Anderson JL; Kayakiri H; Xu H; Becketts K; Smith LE; Bilsky EJ; Davis P; Horvath R
    J Med Chem; 1997 Feb; 40(5):695-704. PubMed ID: 9057856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and pharmacological studies of new hybrid derivatives of fentanyl active at the mu-opioid receptor and I2-imidazoline binding sites.
    Dardonville C; Fernandez-Fernandez C; Gibbons SL; Ryan GJ; Jagerovic N; Gabilondo AM; Meana JJ; Callado LF
    Bioorg Med Chem; 2006 Oct; 14(19):6570-80. PubMed ID: 16797997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.